Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Akari Therapeutics Plc (AKTX)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 27, 2026 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, which was filed on January 23, 2026. They … | Read Filing EDGAR |
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated January 27, 2026, informs Akari Therapeutics that their registration statement on Form S-1, filed on January 23, 2026, will not be reviewed by the SEC… | Read Filing EDGAR |
| Dec. 1, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, originally filed on November 17, 2025. The… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.